Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Safety and Efficacy of AL-8309B Ophthalmic Solution for the Treatment of Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)

NCT00890097 is registered in ClinicalTrials.gov with Alcon Research as lead sponsor.

NCT NCT00890097
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00890097 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Safety and Efficacy of AL-8309B Ophthalmic Solution for the Treatment of Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
Lead sponsor
Alcon Research
Phase
Phase 3
Overall status
Terminated
Start date
April 30, 2009
Completion date
May 31, 2012
Enrollment
772 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration, geographic atrophy